EI9 Stock Overview
Elos Medtech AB (publ) engages in the development and contract manufacturing of medical devices and components for dental, orthopedics, diagnostics, and hearing and other medical device markets.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Elos Medtech AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr17.85 |
52 Week High | kr25.40 |
52 Week Low | kr15.95 |
Beta | 1.12 |
1 Month Change | -1.92% |
3 Month Change | -0.56% |
1 Year Change | -19.59% |
3 Year Change | 75.86% |
5 Year Change | n/a |
Change since IPO | 158.70% |
Recent News & Updates
Recent updates
Shareholder Returns
EI9 | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | 2.6% | -2.6% | -1.3% |
1Y | -19.6% | -0.7% | 4.2% |
Rentabilidad frente al sector: EI9 obtuvo unos resultados inferiores a los del sector German Medical Equipment , que el año pasado arrojó un rendimiento del -2.5%.
Rentabilidad vs. Mercado: EI9 obtuvo unos resultados inferiores a los del mercado German, que fue del 5.9% el año pasado.
Price Volatility
EI9 volatility | |
---|---|
EI9 Average Weekly Movement | 4.5% |
Medical Equipment Industry Average Movement | 5.1% |
Market Average Movement | 4.7% |
10% most volatile stocks in DE Market | 9.8% |
10% least volatile stocks in DE Market | 2.4% |
Precio estable de las acciones: EI9 no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de EI9 (5%) se ha mantenido estable durante el año pasado.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1923 | 653 | Stefano Alfonsi | https://elosmedtech.com |
Elos Medtech AB (publ) Fundamentals Summary
EI9 fundamental statistics | |
---|---|
Market cap | €514.15m |
Earnings (TTM) | €4.93m |
Revenue (TTM) | €91.28m |
104.3x
P/E Ratio5.6x
P/S RatioIs EI9 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
EI9 income statement (TTM) | |
---|---|
Revenue | kr1.02b |
Cost of Revenue | kr676.62m |
Gross Profit | kr341.02m |
Other Expenses | kr286.07m |
Earnings | kr54.95m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Feb 29, 2024
Earnings per share (EPS) | 1.95 |
Gross Margin | 33.51% |
Net Profit Margin | 5.40% |
Debt/Equity Ratio | 51.6% |
How did EI9 perform over the long term?
See historical performance and comparison